Single-port robotic-assisted adrenalectomy

Feasibility, safety, and cost-effectiveness

Arman Arghami, Benzon M. Dy, Juliane Bingener, John Osborn, Melanie L. Richards

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background and Objectives: The introduction of robotic surgery offers patients and surgeons new options for adrenalectomy. Whereas multiport adrenalectomies have been safely performed using the robot, we describe our experience with the novel technique of single-port roboticassisted adrenalectomy. Methods: We performed a matched-cohort study comparing 16 single-port robotic-assisted adrenalectomies with 16 patients from a pool of 148 laparoscopic adrenalectomies, matched for age, gender, operative side, pathology, and body mass index. All were operated on by 1 surgeon. Results: The pathology included aldosteronoma in 44% of patients, adrenocorticotropic hormone–dependent Cushing syndrome (bilateral adrenalectomy) in 19%, pheochromocytoma in 13%, and other pathology in 24%. The operative time was 183 ± 33 minutes for single-port robotic-assisted adrenalectomy and 173 ± 40 minutes for laparoscopic adrenalectomy (P =.58). The total time in the operating room was 246 ± 33 minutes for single-port robotic-assisted adrenalectomy and 240 ± 39 minutes for laparoscopic adrenalectomy (P =.57). There was 1 conversion to open adrenalectomy (6%) in each group, both because of bleeding on the right side during bilateral adrenalectomy. Two right-sided single-port robotic-assisted adrenalectomy patients required conversion to laparoscopic adrenalectomy, one because of poor visualization. There were no deaths. Complications occurred in 2 patients in each group (intensive care unit admission, prolonged ileus). Both groups had similar pain scores (mean of 3.7 on a scale from 1 to 10) on postoperative day 1, and patients in the single-port robotic-assisted adrenalectomy group used less narcotic pain medication in the first 24 hours after surgery (43 mg vs 84 mg in laparoscopic adrenalectomy group, P <.001). The differences between the single-port robotic-assisted adrenalectomy group and laparoscopic adrenalectomy group in length of stay (2.3 ± 0.5 days vs 3.1 ± 0.9 days, P =.23), percentage of patients discharged on postoperative day 1 (56% vs 31%, P =.10), and hospital cost (16% lower in single-port robotic-assisted adrenalectomy group, P =.17) did not reach statistical significance. Conclusion: Single-port robotic adrenalectomy is feasible; patients require less narcotic pain medication whereas costs appear equivalent compared with laparoscopic adrenalectomy.

Original languageEnglish (US)
Article numbere2014.00218
Pages (from-to)1-5
Number of pages5
JournalJournal of the Society of Laparoendoscopic Surgeons
Volume19
Issue number1
DOIs
StatePublished - 2015

Fingerprint

Adrenalectomy
Robotics
Cost-Benefit Analysis
Safety
Narcotics
Pathology
Pain

Keywords

  • Adrenalectomy
  • Laparoscopic
  • Robotic
  • Single port

ASJC Scopus subject areas

  • Surgery

Cite this

Single-port robotic-assisted adrenalectomy : Feasibility, safety, and cost-effectiveness. / Arghami, Arman; Dy, Benzon M.; Bingener, Juliane; Osborn, John; Richards, Melanie L.

In: Journal of the Society of Laparoendoscopic Surgeons, Vol. 19, No. 1, e2014.00218, 2015, p. 1-5.

Research output: Contribution to journalArticle

Arghami, Arman ; Dy, Benzon M. ; Bingener, Juliane ; Osborn, John ; Richards, Melanie L. / Single-port robotic-assisted adrenalectomy : Feasibility, safety, and cost-effectiveness. In: Journal of the Society of Laparoendoscopic Surgeons. 2015 ; Vol. 19, No. 1. pp. 1-5.
@article{4c5813d100af4afc925de9dfea700dd1,
title = "Single-port robotic-assisted adrenalectomy: Feasibility, safety, and cost-effectiveness",
abstract = "Background and Objectives: The introduction of robotic surgery offers patients and surgeons new options for adrenalectomy. Whereas multiport adrenalectomies have been safely performed using the robot, we describe our experience with the novel technique of single-port roboticassisted adrenalectomy. Methods: We performed a matched-cohort study comparing 16 single-port robotic-assisted adrenalectomies with 16 patients from a pool of 148 laparoscopic adrenalectomies, matched for age, gender, operative side, pathology, and body mass index. All were operated on by 1 surgeon. Results: The pathology included aldosteronoma in 44{\%} of patients, adrenocorticotropic hormone–dependent Cushing syndrome (bilateral adrenalectomy) in 19{\%}, pheochromocytoma in 13{\%}, and other pathology in 24{\%}. The operative time was 183 ± 33 minutes for single-port robotic-assisted adrenalectomy and 173 ± 40 minutes for laparoscopic adrenalectomy (P =.58). The total time in the operating room was 246 ± 33 minutes for single-port robotic-assisted adrenalectomy and 240 ± 39 minutes for laparoscopic adrenalectomy (P =.57). There was 1 conversion to open adrenalectomy (6{\%}) in each group, both because of bleeding on the right side during bilateral adrenalectomy. Two right-sided single-port robotic-assisted adrenalectomy patients required conversion to laparoscopic adrenalectomy, one because of poor visualization. There were no deaths. Complications occurred in 2 patients in each group (intensive care unit admission, prolonged ileus). Both groups had similar pain scores (mean of 3.7 on a scale from 1 to 10) on postoperative day 1, and patients in the single-port robotic-assisted adrenalectomy group used less narcotic pain medication in the first 24 hours after surgery (43 mg vs 84 mg in laparoscopic adrenalectomy group, P <.001). The differences between the single-port robotic-assisted adrenalectomy group and laparoscopic adrenalectomy group in length of stay (2.3 ± 0.5 days vs 3.1 ± 0.9 days, P =.23), percentage of patients discharged on postoperative day 1 (56{\%} vs 31{\%}, P =.10), and hospital cost (16{\%} lower in single-port robotic-assisted adrenalectomy group, P =.17) did not reach statistical significance. Conclusion: Single-port robotic adrenalectomy is feasible; patients require less narcotic pain medication whereas costs appear equivalent compared with laparoscopic adrenalectomy.",
keywords = "Adrenalectomy, Laparoscopic, Robotic, Single port",
author = "Arman Arghami and Dy, {Benzon M.} and Juliane Bingener and John Osborn and Richards, {Melanie L.}",
year = "2015",
doi = "10.4293/JSLS.2014.00218",
language = "English (US)",
volume = "19",
pages = "1--5",
journal = "Journal of the Society of Laparoendoscopic Surgeons",
issn = "1086-8089",
publisher = "Society of Laparoendoscopic Surgeons",
number = "1",

}

TY - JOUR

T1 - Single-port robotic-assisted adrenalectomy

T2 - Feasibility, safety, and cost-effectiveness

AU - Arghami, Arman

AU - Dy, Benzon M.

AU - Bingener, Juliane

AU - Osborn, John

AU - Richards, Melanie L.

PY - 2015

Y1 - 2015

N2 - Background and Objectives: The introduction of robotic surgery offers patients and surgeons new options for adrenalectomy. Whereas multiport adrenalectomies have been safely performed using the robot, we describe our experience with the novel technique of single-port roboticassisted adrenalectomy. Methods: We performed a matched-cohort study comparing 16 single-port robotic-assisted adrenalectomies with 16 patients from a pool of 148 laparoscopic adrenalectomies, matched for age, gender, operative side, pathology, and body mass index. All were operated on by 1 surgeon. Results: The pathology included aldosteronoma in 44% of patients, adrenocorticotropic hormone–dependent Cushing syndrome (bilateral adrenalectomy) in 19%, pheochromocytoma in 13%, and other pathology in 24%. The operative time was 183 ± 33 minutes for single-port robotic-assisted adrenalectomy and 173 ± 40 minutes for laparoscopic adrenalectomy (P =.58). The total time in the operating room was 246 ± 33 minutes for single-port robotic-assisted adrenalectomy and 240 ± 39 minutes for laparoscopic adrenalectomy (P =.57). There was 1 conversion to open adrenalectomy (6%) in each group, both because of bleeding on the right side during bilateral adrenalectomy. Two right-sided single-port robotic-assisted adrenalectomy patients required conversion to laparoscopic adrenalectomy, one because of poor visualization. There were no deaths. Complications occurred in 2 patients in each group (intensive care unit admission, prolonged ileus). Both groups had similar pain scores (mean of 3.7 on a scale from 1 to 10) on postoperative day 1, and patients in the single-port robotic-assisted adrenalectomy group used less narcotic pain medication in the first 24 hours after surgery (43 mg vs 84 mg in laparoscopic adrenalectomy group, P <.001). The differences between the single-port robotic-assisted adrenalectomy group and laparoscopic adrenalectomy group in length of stay (2.3 ± 0.5 days vs 3.1 ± 0.9 days, P =.23), percentage of patients discharged on postoperative day 1 (56% vs 31%, P =.10), and hospital cost (16% lower in single-port robotic-assisted adrenalectomy group, P =.17) did not reach statistical significance. Conclusion: Single-port robotic adrenalectomy is feasible; patients require less narcotic pain medication whereas costs appear equivalent compared with laparoscopic adrenalectomy.

AB - Background and Objectives: The introduction of robotic surgery offers patients and surgeons new options for adrenalectomy. Whereas multiport adrenalectomies have been safely performed using the robot, we describe our experience with the novel technique of single-port roboticassisted adrenalectomy. Methods: We performed a matched-cohort study comparing 16 single-port robotic-assisted adrenalectomies with 16 patients from a pool of 148 laparoscopic adrenalectomies, matched for age, gender, operative side, pathology, and body mass index. All were operated on by 1 surgeon. Results: The pathology included aldosteronoma in 44% of patients, adrenocorticotropic hormone–dependent Cushing syndrome (bilateral adrenalectomy) in 19%, pheochromocytoma in 13%, and other pathology in 24%. The operative time was 183 ± 33 minutes for single-port robotic-assisted adrenalectomy and 173 ± 40 minutes for laparoscopic adrenalectomy (P =.58). The total time in the operating room was 246 ± 33 minutes for single-port robotic-assisted adrenalectomy and 240 ± 39 minutes for laparoscopic adrenalectomy (P =.57). There was 1 conversion to open adrenalectomy (6%) in each group, both because of bleeding on the right side during bilateral adrenalectomy. Two right-sided single-port robotic-assisted adrenalectomy patients required conversion to laparoscopic adrenalectomy, one because of poor visualization. There were no deaths. Complications occurred in 2 patients in each group (intensive care unit admission, prolonged ileus). Both groups had similar pain scores (mean of 3.7 on a scale from 1 to 10) on postoperative day 1, and patients in the single-port robotic-assisted adrenalectomy group used less narcotic pain medication in the first 24 hours after surgery (43 mg vs 84 mg in laparoscopic adrenalectomy group, P <.001). The differences between the single-port robotic-assisted adrenalectomy group and laparoscopic adrenalectomy group in length of stay (2.3 ± 0.5 days vs 3.1 ± 0.9 days, P =.23), percentage of patients discharged on postoperative day 1 (56% vs 31%, P =.10), and hospital cost (16% lower in single-port robotic-assisted adrenalectomy group, P =.17) did not reach statistical significance. Conclusion: Single-port robotic adrenalectomy is feasible; patients require less narcotic pain medication whereas costs appear equivalent compared with laparoscopic adrenalectomy.

KW - Adrenalectomy

KW - Laparoscopic

KW - Robotic

KW - Single port

UR - http://www.scopus.com/inward/record.url?scp=84937540459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937540459&partnerID=8YFLogxK

U2 - 10.4293/JSLS.2014.00218

DO - 10.4293/JSLS.2014.00218

M3 - Article

VL - 19

SP - 1

EP - 5

JO - Journal of the Society of Laparoendoscopic Surgeons

JF - Journal of the Society of Laparoendoscopic Surgeons

SN - 1086-8089

IS - 1

M1 - e2014.00218

ER -